Literature DB >> 25232209

In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.

Yu Chen1, Wangxiang Yan1, Shuqi He1, Jiechun Chen1, Dan Chen1, Zhaoqiang Zhang1, Zhiguo Liu1, Xueqiang Ding1, Anxun Wang1.   

Abstract

iASPP is an inhibitory member of the apoptosis-stimulating proteins of P53 (ASPP) family. iASPP is over expressed in several malignant tumors and potentially affects cancer progression. However, the expression and potential role of iASPP in oral tongue squamous cell carcinoma (OTSCC) have not been addressed. In our study, we detected iASPP expression in OTSCC by immunohistochemistry. iASPP expression is up-regulated in OTSCC tissues. Moreover, in clinical pathology specimens, we found that increased iASPP expression correlates with poor differentiation and lymph node metastasis. Using multicellular tumor spheroids (MTS) and flow cytometry, we demonstrated that iASPP down-regulation arrests OTSCC cells at the G0/G1 phase, induces OTSCC cell apoptosis and inhibits OTSCC cell proliferation. These results indicate that iASPP plays a significant role in the progression of OTSCC and may serve as a biomarker or therapeutic target for OTSCC patients.

Entities:  

Keywords:  apoptosis; iASPP; oral tongue squamous cell carcinoma (OTSCC); proliferation

Year:  2014        PMID: 25232209      PMCID: PMC4153930          DOI: 10.3978/j.issn.1000-9604.2014.07.05

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  31 in total

1.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  Expression pattern of the ASPP family members in endometrial endometrioid adenocarcinoma.

Authors:  Wen-Kang Liu; Xiang-Yang Jiang; Jian-Kang Ren; Zhen-Xi Zhang
Journal:  Onkologie       Date:  2010-09-20

3.  A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53.

Authors:  Ze-Jun Liu; Hai-Ming Xin; Jie Chen; Xin Lu; Shan Zhong; Shou-Zhi Gu; Gang Wang; Li Liu; Yun Cai; Lu Hou
Journal:  Leuk Res       Date:  2006-10-19       Impact factor: 3.156

4.  iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.

Authors:  Yun Cai; Shi Qiu; Xing Gao; Shou-Zhi Gu; Ze-Jun Liu
Journal:  Apoptosis       Date:  2012-08       Impact factor: 4.677

Review 5.  The ASPP family: deciding between life and death after DNA damage.

Authors:  Elizabeth A Slee; Xin Lu
Journal:  Toxicol Lett       Date:  2003-04-04       Impact factor: 4.372

Review 6.  ASPP--Apoptotic specific regulator of p53.

Authors:  Ze-Jun Liu; Xin Lu; Shan Zhong
Journal:  Biochim Biophys Acta       Date:  2005-09-25

7.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

8.  The expression of iASPP in acute leukemias.

Authors:  Xinwei Zhang; Min Wang; Chunlin Zhou; Sen Chen; Jianxiang Wang
Journal:  Leuk Res       Date:  2005-02       Impact factor: 3.156

9.  Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.

Authors:  D Waltregny; A Bellahcène; I Van Riet; L W Fisher; M Young; P Fernandez; W Dewé; J de Leval; V Castronovo
Journal:  J Natl Cancer Inst       Date:  1998-07-01       Impact factor: 13.506

10.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.

Authors:  Jinfeng Chen; Fei Xie; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2010-12-30       Impact factor: 4.430

View more
  3 in total

1.  The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.

Authors:  Sarah Kilic; Bernadette Cracchiolo; Molly Gabel; Bruce Haffty; Omar Mahmoud
Journal:  Ann Transl Med       Date:  2015-10

2.  Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.

Authors:  Lian Gong; Yi Hu; Dong He; Yuxing Zhu; Liang Xiang; Mengqing Xiao; Ying Bao; Xiaoming Liu; Qinghai Zeng; Jianye Liu; Ming Zhou; Yanhong Zhou; Yaxin Cheng; Yeyu Zhang; Liping Deng; Rongrong Zhu; Hua Lan; Ke Cao
Journal:  Cancer Cell Int       Date:  2020-05-25       Impact factor: 5.722

Review 3.  Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors.

Authors:  Peixin Dong; Kei Ihira; Junichi Hamada; Hidemichi Watari; Takahiro Yamada; Masayoshi Hosaka; Sharon J B Hanley; Masataka Kudo; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2015-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.